Literature DB >> 3259321

Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.

R Leonard1, D Zagury, I Desportes, J Bernard, J F Zagury, R C Gallo.   

Abstract

A principal feature of acquired immunodeficiency syndrome is depletion of T4 lymphocytes, which is partly due to a direct cytopathic effect of the virus. Both syncytial formation (viral-induced cell fusion) and premature cell death have been cited as the major cause for this phenomenon. By kinetic analysis of cell proliferation and cell lysis we show that the cytopathic effect correlates chiefly with virus production from infected cells, including giant syncytial cells. Most T4 cells were, at least transiently, infected by human immunodeficiency virus (human T-lymphotropic virus type IIIB strain); however, after phytohemagglutinin activation, only 10-30% of infected cells express virus (and die) at any one time, indicating that virus production, followed by cell killing, is linked to immune activation and cell differentiation. We also show that an interval exists before viral release, in which expression of viral antigens occurs on the cell surface, suggesting that infected cells are immunogenic before viral production. If so, they may induce a cell-mediated immune response that could minimize dissemination of human immunodeficiency virus, a possibility that has influenced our approaches to the development of a vaccine for prevention of acquired immunodeficiency syndrome.

Entities:  

Mesh:

Year:  1988        PMID: 3259321      PMCID: PMC280255          DOI: 10.1073/pnas.85.10.3570

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

Authors:  A G Fisher; L Ratner; H Mitsuya; L M Marselle; M E Harper; S Broder; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

2.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

3.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.

Authors:  J Sodroski; W C Goh; C Rosen; K Campbell; W A Haseltine
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

4.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

6.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.

Authors:  D Klatzmann; E Champagne; S Chamaret; J Gruest; D Guetard; T Hercend; J C Gluckman; L Montagnier
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

8.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome-target cell fusion.

Authors:  B Morein; D Barz; U Koszinowski; V Schirrmacher
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  21 in total

1.  Click dimers to target HIV TAR RNA conformation.

Authors:  Sunil Kumar; Patrick Kellish; W Edward Robinson; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Biochemistry       Date:  2012-03-09       Impact factor: 3.162

2.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

Authors:  C Terai; R S Kornbluth; C D Pauza; D D Richman; D A Carson
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo.

Authors:  B D Jamieson; C H Uittenbogaart; I Schmid; J A Zack
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Heterogeneity of the ARV-2 strain and natural isolates of the human immunodeficiency virus.

Authors:  A F Etkin; M I Bukrinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion.

Authors:  E Langhoff; J McElrath; H J Bos; J Pruett; A Granelli-Piperno; Z A Cohn; R M Steinman
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Authors:  A Karpas; G W Fleet; R A Dwek; S Petursson; S K Namgoong; N G Ramsden; G S Jacob; T W Rademacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Induction of apoptosis in a T lymphoblastoid cell line infected with feline immunodeficiency virus.

Authors:  K Ohno; Y Okamoto; T Miyazawa; T Mikami; T Watari; R Goitsuka; H Tsujimoto; A Hasegawa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.

Authors:  K Sakai; X Y Ma; I Gordienko; D J Volsky
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death.

Authors:  V Kolesnitchenko; L M Wahl; H Tian; I Sunila; Y Tani; D P Hartmann; J Cossman; M Raffeld; J Orenstein; L E Samelson; D I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.